BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 5650194)

  • 1. The value of determination of serum creatine phosphokinase activity in detection of carriers of progressive muscular dystrophy.
    Hetnarska L
    Pol Med J; 1968; 7(1):224-7. PubMed ID: 5650194
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tests of serum creatine phosphokinase activity in patients with progressive muscular dystrophy and their relatives for the detection of genetic carriers].
    László A; Salgó L
    Orv Hetil; 1981 Jun; 122(24):1453-6. PubMed ID: 7290660
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum creatine phosphokinase in the detection of carriers of Duchenne's muscular dystrophy in Northern Ireland.
    McCormick D; Allen IV
    Ulster Med J; 1976; 45(1):79-83. PubMed ID: 936362
    [No Abstract]   [Full Text] [Related]  

  • 4. Change of serum creatine phosphokinase activity after exercise in Duchenne type of progressive muscular dystrophy.
    Nakane K
    Nagoya Med J; 1972 Feb; 17(3):203-16. PubMed ID: 5050757
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum creatine phosphokinase activity in Duchenne-type muscular dystrophy and carriers].
    Kato F; Takahashi K
    Iryo; 1968 Dec; 22(12):1386-91. PubMed ID: 5717705
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy.
    Zatz M; Passos MR; Bortolini ER
    Am J Med Genet; 1983 May; 15(1):149-51. PubMed ID: 6859115
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy].
    Ceccarelli A; Leone P
    Clin Pediatr (Bologna); 1967 May; 49(5):237-45. PubMed ID: 6080497
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of serum creatine phosphokinase and its isoenzymes in various muscular diseases].
    László A; Heiner L
    Orv Hetil; 1980 Jan; 121(3):139-40. PubMed ID: 7366978
    [No Abstract]   [Full Text] [Related]  

  • 9. [Creatine phosphokinase activity in serum of carriers of progressive muscular dystrophy of Duchenne type].
    Barthelmai W; Dikbas G; Wüllner S
    Humangenetik; 1969 Oct; 8(2):115-33. PubMed ID: 5365581
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progressive muscular dystrophy and creatine phosphokinase (author's transl)].
    Ebashi S
    Nihon Naika Gakkai Zasshi; 1977 Jul; 66(7):763-8. PubMed ID: 915367
    [No Abstract]   [Full Text] [Related]  

  • 11. Creatine phosphokinase MB band in oculopharyngeal muscular dystrophy.
    Diskin CJ
    N Engl J Med; 1979 Aug; 301(5):270. PubMed ID: 450000
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serum enzyme activities in the families of patients with progressive muscular dystrophy].
    Tani J; Yano I; Masaki H; Fukuyama K; Saeki B
    Iryo; 1967 Jul; 21(7):848-53. PubMed ID: 5582480
    [No Abstract]   [Full Text] [Related]  

  • 13. The detection of female carriers of pseudohypertrophic muscular dystrophy.
    Kakulas BA; Knight JO; Gubbay SS; Mastaglia FL
    Proc Aust Assoc Neurol; 1968; 5(3):545-51. PubMed ID: 5709982
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significances of the elevated activity of serum creatine phosphokinase and transaminase in progressive muscular dystrophy].
    Kondo F; Ikeda M; Abe E; Mue S
    Iryo; 1966 Jul; 20(7):683-93. PubMed ID: 5981769
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of determination of creatine phosphokinase activity in blood serum for detection of carriers of prograssive muscular dystrophy].
    Hetnarska L
    Neurol Neurochir Pol; 1967; 1(5):583-6. PubMed ID: 6064455
    [No Abstract]   [Full Text] [Related]  

  • 16. Hereditary progressive muscular dystrophies: serum myoglobin pattern in patients with different types of muscular dystrophies.
    Pöche H; Kattner E; Beckmann R; Pernice W; Schneider V
    Clin Physiol Biochem; 1989; 7(1):40-6. PubMed ID: 2752671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemical, histological and clinical findings in carriers of Duchenne-type progressive muscular dystrophy].
    Moser H; Mumenthaler M; Wiesmann U
    Schweiz Med Wochenschr; 1971 Apr; 101(15):537-42. PubMed ID: 5576948
    [No Abstract]   [Full Text] [Related]  

  • 18. The value of the determination of cretaine phosphokinase activity (CPK) in certain diseases of the muscles.
    Hetnarska L
    Pol Med J; 1968; 7(3):742-6. PubMed ID: 5669716
    [No Abstract]   [Full Text] [Related]  

  • 19. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possibility of prenatal diagnosis of progressive muscular dystrophy: evaluation of creatine kinase activity in serum and the capping of lymphocytes].
    Venturoli A; Sensi A; Baricordi R; Artioli A; Osti L; Mari R; Ferroni G; Lucci M
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1988-94. PubMed ID: 6608363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.